Directors' / PDMR Dealing and Grant of Options

RNS Number : 5653Q

Futura Medical PLC

13 September 2017

 

13 September 2017

Futura Medical plc

("Futura" or "the Company")

Directors' / PDMR Dealing and Grant of Options

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 12 September 2017 it granted options over a total of 1,440,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") to employees and Directors, of which 1,100,000 options were granted to Directors and PDMRs as detailed below.

Director	Number of options granted	Exercise price	Exercise period	Total number of options held following notification	Total number of Ordinary Shares held
J H Barder	250,000	30.5p	1 Oct 2019 - 30 Sep 2024	1,750,000	1,528,830
D A Martin	200,000	30.5p	1 Oct 2019 - 30 Sep 2024	1,060,000	280,000
K W James	200,000	30.5p	1 Oct 2019 - 30 Sep 2024	400,000	13,787

PDMR	Number of options granted	Exercise price	Exercise period	Total number of options held following notification	Total number of Ordinary Shares held
T Holland	150,000	30.5p	1 Oct 2019 - 30 Sep 2024	917,500	-
I Armstrong	150,000	30.5p	1 Oct 2019 - 30 Sep 2024	550,000	-
R Hawken	150,000	30.5p	1 Oct 2019 - 30 Sep 2024	150,000	-

The 650,000 options granted to: J Barder, D Martin and T Holland were granted under the Futura Medical plc Unapproved Share Option Scheme.

The 450,000 options granted to: K James, I Armstrong and R Hawken and the 340,000 options granted to other employees were granted under the Futura Medical plc Enterprise Management Incentive Scheme.

The main vesting condition of the options is that the Director/PDMR/employee remains employed with the Company as at the date of exercise.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nominated Adviser:
N+1 Singer Aubrey Powell / Liz Yong	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court  / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	James Barder
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 250,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Derek Martin
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 200,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ken James
2	Reason for the notification
a)	Position/status	Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 200,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Tim Holland
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 150,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ian Armstrong
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 150,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Rachael Hawken
2	Reason for the notification
a)	Position/status	PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Futura Medical plc
b)	LEI	21380053QLT46UNV2303
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 0.2p each GB0033278473
b)	Nature of the transactions	Issue of options over Ordinary Shares
c)	Prices and volumes	Price(s) Volume(s) 30.5 pence 150,000
d)	Aggregated information - Aggregated volume - Price	Not applicable
e)	Date of the transactions	12 September 2017
f)	Place of the transactions	Outside a trading venue

 

END

 

 

IOELLFITAIIFLID